Leverage our omni-channel approach to grow your brand across Asia Pacific.
We seek to advance highly specialised and scientifically valuable fields to elevate the standard of healthcare.
Discover more about Menarini Group
For over 30 years, Menarini has been driving research and development to deliver innovative and effective medicines and healthcare solutions for patients affected by serious health conditions.
Gain a single point of entry to all major APAC markets with a direct presence in 13 key markets.
Sharing your partnering idea
Leverage our omni-channel approach to grow your brand across Asia Pacific.
Global Responsibility
FOLLOW US
Global Press Releases
FOLLOW US
MARKETS
The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region.
As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.
Our APAC Headquarters
A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD
30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787
Advanced Diagnostics
We aspire to be a leading provider of diagnostic products and services that informs the most optimal therapeutic decisions for patients with cancer. In our quest to improve diagnostic and therapeutic approaches to human health, we enable the detection and analysis of important but rare cells associated with disease, thereby arming researchers and oncologists with access to unparalleled precision in molecular characterisation.
CellSearch
The CELLSEARCH system and variety of products enables research innovation and supports clinical trial design. These allow researchers to standardise and automate complex sample processing and gain powerful insights into rare cell detection and characterisation.
CellMag
The CellMag product line is designed to streamline the manual immuno-magnetic enrichment and staining of rare CTCs from blood using the ferrofluid technology.
DEPArray™ PLUS
DEPArray™ PLUS is the new automated and versatile platform to sort pre-selected rare cell populations from a variety of sample types with single cell precision and 100% purity.
DEPArray™ Technology
This automated platform enables users to identify and recover specific individual cells of interest from complex, heterogeneous samples.
VRNxT
VRNxT is a sample preparation instrument that automates the volume reduction steps in rare cell analysis workflow.
DEPArray™ Kits
The DEPArray Kits streamline and optimise the analysis of FFPE samples by providing DEPArray users with a fast and easy workflow for a precise genetic analysis on pure cancer and stromal cell populations.
Ampli1™ Kits
Ampli1 kits provide a complete range of products covering the entire workflow and are optimised for different kinds of genetic analysis on the amplified DNA.
MSBiosuite
MSBiosuite automates the processing of sequencing data and provides highly confident variant calling and generation of copy number aberration profiles.
Research Lab Service
Research Lab Service allows investigators to leverage the benefits of our technology and scientific expertise using their own samples and get back results and data generated with our workflows.
APAC Compliance
We seek to provide healthcare professionals with the best possible solutions for their diagnostics needs and improve patients’ prognoses and quality of life.